Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +38.90%
#2 Siren Siren +30.85%
#3 Purr Purr +26.84%
#4 Prom Prom +18.94%
#5 Pendle Pendle +17.96%
#6 DigiByte DigiByte +17.66%
#7 OriginTrail OriginTrail +17.10%
#8 UnifAI Network UnifAI Network +15.42%
#9 Plasma Plasma +13.17%
#10 Unit Plasma Unit Plasma +13.17%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Hemab Therapeutics Holdings, Inc. Common Stock Hemab Therapeutics Holdings, Inc. Common Stock

Hemab Therapeutics Holdings, Inc. Common Stock

COAG
Rang in Aktien #21709
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm... Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology firm dedicated to transforming the treatment of blood coagulation disorders. Operating in the United States and Denmark, its mission is to enhance life and resilience for patients through innovative therapies. The company's leading pipeline candidate is HMB-001, a bispecific antibody. This asset is currently undergoing Phase 1/2 clinical trials for the preventive management of Glanzmann thrombasthenia and has progressed to Phase 2 for the prophylactic treatment of Factor VII deficiency. Additionally, Hemab is advancing HMB-002, a monovalent antibody, through Phase 1/2 clinical development. This drug is designed for the subcutaneous prophylactic treatment of Von Willebrand disease. Beyond these clinical assets, the company actively pursues numerous preclinical and discovery-stage programs. Established in 2020, Hemab Therapeutics Holdings, Inc. maintains its headquarters in Cambridge, Massachusetts.
Aktienkurs
$50.82
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$102.09M
Veränderung (1 Tag)
1.90%
Veränderung (1 Jahr)
-
Land
US
Handel Hemab Therapeutics Holdings, Inc. Common Stock (COAG)

Kategorie

Healthcare
Kursverlauf für Hemab Therapeutics Holdings, Inc. Common Stock (COAG)
Höchster Schlusskurs: $50.63 am 2026-08-01

Niedrigster Schlusskurs: $27.02 am 2026-05-01
Kursverlauf der Aktie von Hemab Therapeutics Holdings, Inc. Common Stock von 2026 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
Nicht genügend Daten für die angegebenen Daten.
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH